Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

136,142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dupilumab Versus Mepolizumab for Chronic Rhinosinusitis With Nasal Polyposis: An Indirect Treatment Comparison.
Hopkins C, Han JK, Fokkens W, Wagenmann M, Guyot P, Khan AH, Nash S, Wang Z, Xu Y, Msihid J, Neupane B, Nag A, Bachert C. Hopkins C, et al. Among authors: wang z. J Allergy Clin Immunol Pract. 2024 Sep 24:S2213-2198(24)00941-3. doi: 10.1016/j.jaip.2024.09.015. Online ahead of print. J Allergy Clin Immunol Pract. 2024. PMID: 39326524 Free article.
Letter to the Editor Regarding 'Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab Versus Dupilumab in Moderate-to-Severe Atopic Dermatitis'.
Bastian M, Freemantle N, Rossi AB, Shumel B, Le Bagousse GB, Wang Z, Xu Y, Guyot P. Bastian M, et al. Among authors: wang z. Dermatol Ther (Heidelb). 2024 Mar;14(3):819-821. doi: 10.1007/s13555-024-01106-2. Epub 2024 Feb 16. Dermatol Ther (Heidelb). 2024. PMID: 38366176 Free PMC article. No abstract available.
Comparative effectiveness of dupilumab and omalizumab on asthma exacerbations and systemic corticosteroid prescriptions: Real-world US ADVANTAGE study.
Bleecker E, Blaiss M, Jacob-Nara J, Huynh L, Duh MS, Guo T, Ye M, Stanford RH, Wang Z, Soler X, Nag A, Nair R, Borsos K. Bleecker E, et al. Among authors: wang z. J Allergy Clin Immunol. 2024 Aug 24:S0091-6749(24)00865-0. doi: 10.1016/j.jaci.2024.07.029. Online ahead of print. J Allergy Clin Immunol. 2024. PMID: 39186985 Free article.
Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study.
Kimball AB, Delevry D, Yang M, Chuang CC, Wang Z, Bégo-Le-Bagousse G, Martins B, Wu E, Shumel B, Wang J, Sierka D, Chao J, Strober B. Kimball AB, et al. Among authors: wang z, wang j. Dermatol Ther (Heidelb). 2023 Sep;13(9):2107-2120. doi: 10.1007/s13555-023-00965-5. Epub 2023 Aug 8. Dermatol Ther (Heidelb). 2023. PMID: 37552431 Free PMC article.
The effect of dupilumab on caregiver- and patient-reported outcomes in young children with moderate-to-severe atopic dermatitis: Results from a placebo-controlled, phase 3 study.
Paller AS, Silverberg JI, Simpson EL, Cork MJ, Arkwright PD, Chen Z, Bansal A, Prescilla R, Wang Z, Marco AR. Paller AS, et al. Among authors: wang z. J Am Acad Dermatol. 2024 Sep 28:S0190-9622(24)02896-2. doi: 10.1016/j.jaad.2024.09.039. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 39349183 Free article.
136,142 results
You have reached the last available page of results. Please see the User Guide for more information.